Overview
Pierpaolo Pattacini practices in Reggio Nell'emilia, Italy. Pattacini is rated as a Distinguished expert by MediFind in the treatment of Congenital Bowing of Long Bones. Their top areas of expertise are Congenital Bowing of Long Bones, Femoral Facial Syndrome, Retroperitoneal Fibrosis, and Lissencephaly 2.
Their clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Congenital Bowing of Long Bones.
Locations
Reggio Nell'emilia, Italy
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Congenital Bowing of Long BonesPattacini isDistinguished. Learn about Congenital Bowing of Long Bones.
- Advanced
- Femoral Facial SyndromePattacini isAdvanced. Learn about Femoral Facial Syndrome.
- Retroperitoneal FibrosisPattacini isAdvanced. Learn about Retroperitoneal Fibrosis.
- Experienced
- Breast CancerPattacini isExperienced. Learn about Breast Cancer.
- CalcinosisPattacini isExperienced. Learn about Calcinosis.
- Campomelia Cumming TypePattacini isExperienced. Learn about Campomelia Cumming Type.
- Campomelic DysplasiaPattacini isExperienced. Learn about Campomelic Dysplasia.
- ChondrodystrophyPattacini isExperienced. Learn about Chondrodystrophy.
- Colorectal CancerPattacini isExperienced. Learn about Colorectal Cancer.